Lixte Biotechnology Holdings Inc (LIXT) — Financial Flexibility Index
Lixte Biotechnology Holdings Inc (LIXT) has a Financial Flexibility Index of -0.61x as of December 2025. Free cash flow of $-1.09 Million (operating CF $-1.09 Million minus capex $3.00) represents -1% of total liabilities ($1.77 Million). Also explore Lixte Biotechnology Holdings Inc (LIXT) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lixte Biotechnology Holdings Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Lixte Biotechnology Holdings Inc across 21 annual periods. Check LIXT cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Lixte Biotechnology Holdings Inc (2005–2025)
Year-by-year free cash flow to debt coverage for Lixte Biotechnology Holdings Inc. For the full company profile including market capitalisation, see Lixte Biotechnology Holdings Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.60K | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-442.95K | $-443.45K | $124.50K | ▼ -35.3% |
| 2005 | -2.63x | $-32.87K | $-32.87K | $12.50K | — |